Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide

Published reports suggest that immune checkpoint inhibitors (ICIs) before allogeneic blood or marrow transplantation (alloBMT) may increase the incidence of graft-versus-host disease (GvHD), immune-related adverse events, and nonrelapse mortality (NRM); this led to the US Food and Drug Administratio...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood Adv
Hlavní autoři: Schoch, Laura K., Cooke, Kenneth R., Wagner-Johnston, Nina D., Gojo, Ivana, Swinnen, Lode J., Imus, Philip, Fuchs, Ephraim J., Levis, Mark, Ambinder, Richard F., Jones, Richard J., Gladstone, Douglas E.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2018
Témata:
Transplantation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134225/
https://ncbi.nlm.nih.gov/pubmed/30190282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018019208
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky